Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
uniQure
Biotech
uniQure Huntington's gene therapy data 'on the favorable side'
The principal investigator for uniQure’s Huntington’s disease gene therapy says efficacy signals are “on the favorable side.”
Annalee Armstrong
Dec 19, 2023 11:28am
Lilly picks new head of diabetes, obesity unit—Chutes & Ladders
Oct 6, 2023 9:30am
uniQure lays off 5th of staff to fund gene therapy trials
Oct 5, 2023 10:35am
Gene therapy biotech uniQure's stock sinks after hazy data drop
Jun 21, 2023 4:02pm
UniQure snags rare ALS therapy from Apic Bio for $10M upfront
Jan 31, 2023 10:45am
Bristol Myers scraps uniQure cardiovascular gene therapy pact
Nov 29, 2022 8:15am